MCID: PLY040
MIFTS: 50

Polymorphous Low-Grade Adenocarcinoma malady

Rare diseases category

Summaries for Polymorphous Low-Grade Adenocarcinoma

About this section
Sources:
66Wikipedia, 34MalaCards
See all sources

Fully expand this MalaCard

Download this MalaCard
Wikipedia:66 Polymorphous low-grade adenocarcinoma, often abbreviated PLGA, is a rare, asymptomatic, slow-growing... more...

MalaCards: Polymorphous Low-Grade Adenocarcinoma, also known as polymorphous low grade adenocarcinoma, is related to adenoid cystic carcinoma and adenocarcinoma. An important gene associated with Polymorphous Low-Grade Adenocarcinoma is SERPINB5 (serpin peptidase inhibitor, clade B (ovalbumin), member 5), and among its related pathways are Advanced glycosylation endproduct receptor signaling and Lymphocyte Signaling. The compounds s 100 and orcein have been mentioned in the context of this disorder. Affiliated tissues include salivary gland, tongue and lung, and related mouse phenotypes are limbs/digits/tail and tumorigenesis.

Aliases & Classifications for Polymorphous Low-Grade Adenocarcinoma

About this section
Sources:
44NIH Rare Diseases, 63UMLS
See all sources

Classifications:

Malacards categories (disease lists): (See all malacards categories)
Global: Rare diseases


Aliases & Descriptions:

polymorphous low-grade adenocarcinoma 44
polymorphous low grade adenocarcinoma 63


Related Diseases for Polymorphous Low-Grade Adenocarcinoma

About this section
Sources:
18GeneCards, 19GeneDecks
See all sources

Diseases related to Polymorphous Low-Grade Adenocarcinoma via text searches within MalaCards or GeneCards/GeneDecks gene sharing:

(show top 50)    (show all 153)
idRelated DiseaseScoreTop Affiliating Genes
1adenoid cystic carcinoma31.5NFIB, MYB
2adenocarcinoma31.4CTNNB1, PCNA, ACTC1, NTRK3, CCND1, LGALS3
3adenoma30.8CTNNB1, S100A1, PCNA, ACTC1, CCND1, LGALS3
4pleomorphic adenoma30.7S100B, S100A1, PCNA, ACTC1, MUC1, MYH11
5cystadenocarcinoma30.5CEACAM3, MUC1
6myoepithelioma30.4S100B, S100A1, ACTC1, VIM, SERPINB5, TP63
7adenoiditis10.9
8nasopharyngitis10.2
9tonsillitis10.2
10papillary cystadenocarcinoma10.2
11adenocarcinoma in situ10.2
12cervicitis10.2
13papillary adenocarcinoma10.2
14nephrogenic adenoma10.1S100A1
15pericardial effusion10.1CHKB
16multicystic dysplastic kidney10.1LGALS3
17histiocytosis10.1S100B
18hidradenoma10.1MUC1
19carney triad10.1KIT
20juvenile xanthogranuloma10.1S100B
21cholesteatoma10.1S100A1, LGALS3
22langerhans-cell histiocytosis10.1S100B, S100A1
23rosai-dorfman disease10.1S100B
24epithelioid leiomyosarcoma10.1ACTC1, VIM
25fibrous meningioma10.1S100B, MUC1
26clear cell ependymoma10.1MUC1, VIM
27anaplastic ependymoma10.1S100B, MUC1
28choroid plexus papilloma10.1S100B, MUC1
29mucinous cystadenocarcinoma10.1CEACAM3, MUC1
30mesenchymal chondrosarcoma10.1MUC1, VIM
31cutaneous paget's disease10.1CEACAM3, MUC1
32adenomatoid tumor10.1VIM
33cutaneous fibrous histiocytoma10.1S100B, S100A1, ACTC1
34glomus tumor10.1S100A1, ACTC1, VIM
35clear cell sarcoma10.1KIT, S100B
36fibroma10.1S100A1, ACTC1, VIM
37sertoli cell tumor10.1MUC1, VIM
38epithelioid sarcoma10.1MUC1, VIM
39intraductal papilloma10.1MYH11, TP63
40pulmonary alveolar proteinosis10.1CEACAM3, MUC1
41congenital mesoblastic nephroma10.1NTRK3
42granular cell tumor10.1S100B, S100A1, VIM
43secretory meningioma10.1MUC1, VIM
44paraganglioma10.1KIT, S100B, S100A1
45ectopic pregnancy10.1CHKB, MYH11
46rhabdoid tumor10.1ACTC1, MUC1, VIM
47fibrous histiocytoma10.1S100B, ACTC1, VIM
48renal clear cell carcinoma10.1S100A1, MUC1, VIM
49angiosarcoma10.1ACTC1, MUC1, VIM
50perineurioma10.1S100B, MUC1, VIM

Graphical network of the top 20 diseases related to Polymorphous Low-Grade Adenocarcinoma:



Diseases related to polymorphous low-grade adenocarcinoma

Symptoms for Polymorphous Low-Grade Adenocarcinoma

About this section

Drugs & Therapeutics for Polymorphous Low-Grade Adenocarcinoma

About this section
Sources:
6CenterWatch, 43NIH Clinical Center, 7ClinicalTrials
See all sources

Approved drugs:

Search CenterWatch for Polymorphous Low-Grade Adenocarcinoma

Drug clinical trials:

Search ClinicalTrials for Polymorphous Low-Grade Adenocarcinoma

Search NIH Clinical Center for Polymorphous Low-Grade Adenocarcinoma

Search CenterWatch for Polymorphous Low-Grade Adenocarcinoma

Genetic Tests for Polymorphous Low-Grade Adenocarcinoma

About this section

Anatomical Context for Polymorphous Low-Grade Adenocarcinoma

About this section
Sources:
34MalaCards
See all sources

MalaCards organs/tissues related to Polymorphous Low-Grade Adenocarcinoma:

34
Salivary gland, Tongue, Lung, Lymph node, Skin, Smooth muscle, Breast, Tonsil, Pituitary

Animal Models for Polymorphous Low-Grade Adenocarcinoma or affiliated genes

About this section
Sources:
38MGI
See all sources

MGI Mouse Phenotypes related to Polymorphous Low-Grade Adenocarcinoma:

38 (show all 23)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053718.8CTNNB1, KIT, CHKB, ESR1, TP63
2MP:00020068.6TP63, ESR1, MUC1, CCND1, KIT, CTNNB1
3MP:00053678.5TP63, ESR1, MYH11, LGALS3, KIT, CTNNB1
4MP:00053908.4TP63, ESR1, CHKB, LGALS3, CCND1, KIT
5MP:00053808.4TP63, SERPINB5, ESR1, VIM, MYB, KIT
6MP:00053818.3TP63, ESR1, MYH11, MUC1, LGALS3, CCND1
7MP:00030128.2ESR1, MYB, MUC1, NTRK3, PCNA, KIT
8MP:00053798.1TP63, ESR1, MUC1, CCND1, PCNA, KIT
9MP:00053897.9TP63, ESR1, VIM, LGALS3, CCND1, PCNA
10MP:00053847.8VIM, ESR1, SERPINB5, TP63, MYB, LGALS3
11MP:00053697.8TP63, ESR1, VIM, MYH11, CHKB, ACTC1
12MP:00107717.8TP63, ESR1, MYB, MYH11, MUC1, LGALS3
13MP:00053917.7TP63, VIM, MUC1, CCND1, NTRK3, KIT
14MP:00053877.7TP63, ESR1, VIM, MYB, LGALS3, CCND1
15MP:00028737.6CCND1, MUC1, MYB, TP63, NTRK3, ACTC1
16MP:00053977.5ESR1, VIM, MYB, LGALS3, CCND1, PCNA
17MP:00053867.3TP63, ESR1, VIM, CHKB, CCND1, NTRK3
18MP:00036317.2ESR1, VIM, CHKB, LGALS3, CCND1, NTRK3
19MP:00053887.0MYH11, VIM, ESR1, TP63, LGALS3, CCND1
20MP:00053856.9CTNNB1, TP63, ESR1, VIM, MYB, MYH11
21MP:00053766.7MUC1, MYH11, VIM, ESR1, TP63, CHKB
22MP:00053786.3MYH11, MYB, VIM, ESR1, TP63, CCND1
23MP:00107685.9MYH11, MYB, VIM, ESR1, SERPINB5, TP63

Publications for Polymorphous Low-Grade Adenocarcinoma

About this section
Sources:
53PubMed
See all sources

Articles related to Polymorphous Low-Grade Adenocarcinoma:

(show top 50)    (show all 144)
idTitleAuthorsYear
1
Immunohistochemical clue for the histological overlap of salivary adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma. (24265903)
2013
2
Polymorphous low-grade adenocarcinoma of the maxillary sinus. (23714964)
2013
3
Polymorphous low-grade adenocarcinoma of the upper lip with metachronous myoepithelioma of the buccal mucosa. (24268388)
2013
4
Polymorphous Low-Grade Adenocarcinoma (PLGA) in an 18-Year-Old Male. (24426416)
2013
5
Polymorphous low-grade adenocarcinoma located in the maxillary sinus. (23011832)
2012
6
Studies of genomic imbalances and the MYB-NFIB gene fusion in polymorphous low-grade adenocarcinoma of the head and neck. (21901247)
2012
7
Polymorphous low-grade adenocarcinoma: the University of Pittsburgh experience. (20403856)
2010
8
Polymorphous low-grade adenocarcinoma of parotid gland: a rare occurrence. (19136798)
2009
9
Comparison of immunohistochemical markers between adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma. (20032601)
2009
10
Polymorphous low-grade adenocarcinoma of the nasopharynx: a case report and brief review. (18820100)
2008
11
Low-grade papillary adenocarcinoma of the palate: the significance of distinguishing it from polymorphous low-grade adenocarcinoma. (20614302)
2008
12
Polymorphous low-grade adenocarcinoma of the head and neck. (18327037)
2008
13
Galectin-3 immunoprofile in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of salivary glands. (16996782)
2007
14
Selective immunohistochemical comparison of polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma. (16487803)
2006
15
Retrospective study and review of polymorphous low-grade adenocarcinoma. (17146387)
2006
16
Polymorphous low-grade adenocarcinoma of the nasal fossa. (16056192)
2005
17
Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas. (15153875)
2004
18
Polymorphous low-grade adenocarcinoma of the major salivary glands: report of three cases in an unusual location. (14764060)
2004
19
Polymorphous low-grade adenocarcinoma--a rare and aggressive entity in adolescence. (15121262)
2004
20
Polymorphous low grade adenocarcinoma of the parotid gland. Cytological, histological and immunohistochemical features and review of the literature. (15168873)
2004
21
Polymorphous low-grade adenocarcinoma of the tongue. (15041060)
2004
22
Polymorphous low-grade adenocarcinoma of the salivary glands with transformation to high-grade carcinoma. (12207787)
2002
23
Cytogenetic similarities between two types of salivary gland carcinomas: adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma. (11463451)
2001
24
Polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma: distinct architectural composition revealed by collagen IV, laminin and their integrin ligands (alpha2beta1 and alpha3beta1). (10931234)
2000
25
Polymorphous low grade adenocarcinoma with distant metastases and deletions on chromosome 6q23-qter and 11q23-qter: a case report. (11265182)
2000
26
Polymorphous low-grade adenocarcinoma of the submandibular gland. (10964318)
2000
27
Histologic transformation of polymorphous low-grade adenocarcinoma of salivary gland. (10361514)
1999
28
Polymorphous low grade adenocarcinoma: a clinicopathologic study of 164 cases. (10421256)
1999
29
Characterization of the cellular component of polymorphous low-grade adenocarcinoma by immunohistochemistry and electron microscopy. (10435151)
1999
30
Polymorphous low-grade adenocarcinoma of the parotid gland. (9758181)
1998
31
Polymorphous low-grade adenocarcinoma of the parotid gland. (9825934)
1998
32
Polymorphous low-grade adenocarcinoma: flow cytometric, p53, and PCNA analysis. (9347503)
1997
33
Regional metastasis in polymorphous low grade adenocarcinoma. Report of a case. (9418148)
1997
34
Polymorphous low-grade adenocarcinoma (PLGA) of the tongue. (9102454)
1997
35
Assessment of proliferative activity using the MIB1 antibody help to distinguish polymorphous low grade adenocarcinoma from adenoid cystic carcinoma of salivary glands. (9505262)
1997
36
Polymorphous low-grade adenocarcinoma of the palate in a 16-year-old male patient. (8971451)
1996
37
Polymorphous low-grade adenocarcinoma of parotid gland. (8866071)
1996
38
Case presentation. Polymorphous low-grade adenocarcinoma: a minor salivary gland malignancy with benign clinical features. (9569846)
1996
39
Polymorphous low-grade adenocarcinoma of the tongue. (8759555)
1996
40
Simultaneous multifocal polymorphous low-grade adenocarcinoma. Report of two cases. (7552866)
1995
41
Polymorphous low-grade adenocarcinoma arising in the nasal cavities with an associated undifferentiated carcinoma. (7483012)
1995
42
Clinical and therapeutic features of polymorphous low-grade adenocarcinoma. (8108096)
1994
43
Argyrophilia in nucleolar organizer regions (AgNOR) in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of the salivary glands. (7690237)
1993
44
Polymorphous low-grade adenocarcinoma. (1607159)
1992
45
Polymorphous low-grade adenocarcinoma: a 'new' salivary gland tumour. (2008296)
1991
46
Polymorphous low-grade adenocarcinoma of the salivary glands: a clinicopathological comparison with adenoid cystic carcinoma. (1661700)
1991
47
Karyotypic variability and evolutionary characteristics of a polymorphous low grade adenocarcinoma in the parotid gland. (1913603)
1991
48
Case for diagnosis. Polymorphous low-grade adenocarcinoma of minor salivary gland origin. (3133600)
1988
49
Polymorphous low-grade adenocarcinoma of minor salivary gland. An immunohistochemical and clinicopathologic study. (2837102)
1988
50
Polymorphous low-grade adenocarcinoma of minor salivary glands. A study of 14 cases of a distinctive neoplasm. (6692293)
1984

Variations for Polymorphous Low-Grade Adenocarcinoma

About this section

Expression for genes affiliated with Polymorphous Low-Grade Adenocarcinoma

About this section
Sources:
2BioGPS, 16Gene Expression Omnibus DataSets
See all sources
Expression patterns in normal tissues for genes affiliated with Polymorphous Low-Grade Adenocarcinoma

Search GEO for disease gene expression data for Polymorphous Low-Grade Adenocarcinoma.

Pathways for genes affiliated with Polymorphous Low-Grade Adenocarcinoma

About this section
Sources:
51PathCards, 56Reactome, 5Cell Signaling Technology, 39NCBI BioSystems Database, 54QIAGEN, 31KEGG, 61Thomson Reuters
See all sources

Pathways related to Polymorphous Low-Grade Adenocarcinoma according to GeneCards/GeneDecks:

(show all 17)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
110.0S100B, LGALS3
29.8KIT, LGALS3, MYB
3
Show member pathways
9.7ACTC1, MYH11, VIM
49.7CCND1, ESR1
59.6CCND1, LGALS3, VIM
69.6KIT, CCND1, MYB
79.4PCNA, SERPINB5, TP63
89.3TP63, SERPINB5, VIM, CCND1
99.3ESR1, CCND1, CTNNB1
109.3CTNNB1, CCND1, ESR1
119.3ESR1, CCND1, CTNNB1
129.0MYB, CCND1, PCNA, CTNNB1
13
Show member pathways
Signal transduction PTEN pathway61
9.0CCND1, PCNA, KIT, CTNNB1
14
Show member pathways
Cytoskeleton remodeling Fibronectin binding integrins in cell motility61
Cytoskeleton remodeling Integrin outside in signaling61
Cytoskeleton remodeling Regulation of actin cytoskeleton by Rho GTPases61
Cell adhesion Tight junctions61
Development MAG dependent inhibition of neurite outgrowth61
8.8MYH11, CCND1, NTRK3, ACTC1, CTNNB1
158.8CTNNB1, PCNA, CCND1, ESR1
16
Show member pathways
8.7ESR1, VIM, NTRK3, KIT, CTNNB1
17
Show member pathways
7.8CTNNB1, ESR1, VIM, MYH11, MUC1, CCND1

Compounds for genes affiliated with Polymorphous Low-Grade Adenocarcinoma

About this section
Sources:
46Novoseek, 52PharmGKB, 12DrugBank, 25HMDB, 30IUPHAR, 62Tocris Bioscience
See all sources

Compounds related to Polymorphous Low-Grade Adenocarcinoma according to GeneCards/GeneDecks:

(show top 50)    (show all 153)
idCompoundScoreTop Affiliating Genes
1s 100469.9MUC1, ACTC1, S100B, VIM
2orcein469.6ACTC1, S100B, VIM
3eosin469.6S100B, PCNA, MUC1, VIM
42-methoxyethanol469.5ACTC1, VIM, S100A1, TP63
5reticulin469.4ACTC1, PCNA, VIM, S100B, MUC1
6trastuzumab46 52 1211.1ESR1, MUC1, CCND1, KIT, CTNNB1
74-hydroxytamoxifen469.1CTNNB1, S100B, CCND1, VIM, ESR1
8agar469.0CTNNB1, LGALS3, CHKB, MUC1, VIM, CCND1
9gefitinib46 52 1211.0KIT, CTNNB1, VIM, ESR1, CCND1
10imatinib46 52 1210.8CTNNB1, CCND1, NTRK3, MYB, ACTC1, S100B
11biotin46 25 1210.7CTNNB1, VIM, ACTC1, MUC1, PCNA, S100A1
12butyrate468.6MUC1, LGALS3, CCND1, PCNA, MYB, CTNNB1
13adriamycin468.6VIM, MUC1, CEACAM3, CCND1, CTNNB1
14dihydrotestosterone46 30 25 1211.6CTNNB1, VIM, ESR1, CHKB, MUC1
15formaldehyde46 259.6KIT, VIM, MUC1, CCND1, ACTC1, PCNA
16bromodeoxyuridine468.5S100B, PCNA, CCND1, MYB, VIM, TP63
17glutamine468.5VIM, CHKB, LGALS3, PCNA, S100B, KIT
18estradiol46 25 1210.5CHKB, CCND1, PCNA, ESR1, VIM, MYB
19mucicarmine468.5ACTC1, S100A1, S100B, CEACAM3, MUC1, VIM
20dexamethasone46 52 30 1211.4VIM, MUC1, S100B, ACTC1, CTNNB1, MYB
21threonine468.3NTRK3, MUC1, MYB, CTNNB1, S100B, KIT
22lactate468.3CEACAM3, CHKB, VIM, S100B, LGALS3, PCNA
23matrigel468.3SERPINB5, VIM, MUC1, LGALS3, NTRK3, CCND1
24paclitaxel46 52 1210.3ESR1, VIM, CCND1, PCNA, S100B, KIT
25creatinine468.3CHKB, PCNA, S100B, VIM, MUC1, CEACAM3
26arginine468.3LGALS3, CHKB, PCNA, MYB, S100B, CTNNB1
275fluorouracil468.3PCNA, CTNNB1, MUC1, KIT, ESR1, CEACAM3
28oligonucleotide468.3PCNA, CCND1, KIT, LGALS3, MYB, VIM
29cisplatin46 52 62 1211.2TP63, CTNNB1, SERPINB5, ESR1, MUC1, LGALS3
30cycloheximide468.2NTRK3, ESR1, VIM, CCND1, KIT, CTNNB1
31serine468.0MYH11, LGALS3, S100B, MUC1, VIM, MYB
32nitric oxide46 25 1210.0LGALS3, CHKB, CEACAM3, KIT, S100B, MYH11
33glycogen46 259.0CTNNB1, KIT, S100B, S100A1, ACTC1, VIM
34doxorubicin46 52 1210.0KIT, CTNNB1, CCND1, CEACAM3, MYB, VIM
35b 723467.9TP63, VIM, MUC1, CEACAM3, ACTC1, PCNA
36methotrexate52 46 129.9PCNA, KIT, CEACAM3, CCND1, ESR1, CHKB
37alanine467.9CEACAM3, LGALS3, VIM, CTNNB1, S100B, PCNA
38aspartate467.9CEACAM3, KIT, CTNNB1, S100B, CHKB, VIM
39cysteine467.7KIT, CTNNB1, S100A1, VIM, LGALS3, MYB
40tamoxifen46 52 30 1210.6SERPINB5, ESR1, VIM, MUC1, CHKB, CEACAM3
41thymidine46 258.5CEACAM3, CCND1, TP63, MYB, KIT, S100B
42steroid467.4CCND1, TP63, ESR1, MYB, CHKB, CEACAM3
43hematoxylin467.2S100B, S100A1, KIT, PCNA, ACTC1, LGALS3
44tyrosine466.9TP63, LGALS3, CTNNB1, S100B, MUC1, S100A1
45testosterone46 62 25 129.8CTNNB1, KIT, S100B, PCNA, ACTC1, NTRK3
46retinoic acid46 257.0VIM, ESR1, TP63, PCNA, MYB, CTNNB1
47paraffin465.6CTNNB1, KIT, S100B, S100A1, PCNA, ACTC1
48progesterone46 30 62 25 129.6ACTC1, CTNNB1, KIT, S100B, S100A1, PCNA
49vegf465.4MYH11, MUC1, CHKB, LGALS3, CCND1, NTRK3
50estrogen465.3LGALS3, MYH11, MYB, VIM, ESR1, CCND1

GO Terms for genes affiliated with Polymorphous Low-Grade Adenocarcinoma

About this section
Sources:
17Gene Ontology
See all sources

Cellular components related to Polymorphous Low-Grade Adenocarcinoma according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1extracellular vesicular exosomeGO:0700628.6MUC1, LGALS3, ACTC1, PCNA, CTNNB1, VIM
2cytoplasmGO:0057377.2CTNNB1, TP63, SERPINB5, VIM, MUC1, LGALS3

Biological processes related to Polymorphous Low-Grade Adenocarcinoma according to GeneCards/GeneDecks:

(show all 16)
idNameGO IDScoreTop Affiliating Genes
1DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorGO:00697810.1TP63, MUC1
2mitotic G1 DNA damage checkpointGO:03157110.0CCND1, TP63
3positive regulation of phospholipase C activityGO:01086310.0KIT, ESR1
4epithelial cell developmentGO:00206410.0ESR1, TP63
5response to X-rayGO:0101659.9CCND1, TP63
6mammary gland alveolus developmentGO:0607499.9ESR1, CCND1
7positive regulation of Notch signaling pathwayGO:0457479.8TP63, KIT
8response to corticosteroneGO:0514129.8CCND1, NTRK3
9proximal/distal pattern formationGO:0099549.8CTNNB1, TP63
10response to ethanolGO:0454719.8CCND1, NTRK3, ACTC1
11chromatin remodelingGO:0063389.7TP63, ESR1, MYB
12hindbrain developmentGO:0309029.4CTNNB1, NFIB
13G1/S transition of mitotic cell cycleGO:0000829.4PCNA, CCND1, MYB
14response to cadmium ionGO:0466869.3CTNNB1, PCNA
15positive regulation of transcription from RNA polymerase II promoterGO:0459448.5TP63, ESR1, MYB, NFIB, CTNNB1
16negative regulation of transcription from RNA polymerase II promoterGO:0001228.2CTNNB1, NFIB, S100A1, CCND1, MYB, TP63

Molecular functions related to Polymorphous Low-Grade Adenocarcinoma according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1S100 protein bindingGO:0445489.6S100A1, S100B
2p53 bindingGO:0020399.5NTRK3, MUC1, TP63
3double-stranded DNA bindingGO:0036909.0CTNNB1, NFIB, TP63
4chromatin bindingGO:0036828.8CTNNB1, MYB, ESR1, TP63
5identical protein bindingGO:0428028.2TP63, ESR1, VIM, PCNA, S100A1, S100B
6protein bindingGO:0055156.1CTNNB1, TP63, SERPINB5, ESR1, VIM, MYB

Products for genes affiliated with Polymorphous Low-Grade Adenocarcinoma

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies

Sources for Polymorphous Low-Grade Adenocarcinoma

About this section
4CDC
14ExPASy
15FMA
23GTR
24HGMD
25HMDB
26ICD10
27ICD10 via Orphanet
28ICD9CM
30IUPHAR
31KEGG
36MeSH
37MESH via Orphanet
38MGI
41NCIt
42NDF-RT
45NINDS
46Novoseek
48OMIM
49OMIM via Orphanet
53PubMed
54QIAGEN
60SNOMED-CT via Orphanet
63UMLS
64UMLS via Orphanet